Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions

Cancer

Volumn 82, Issue 5, 1998, Pages 936-943

  Oude Ophuis, Michael B ^a   Van Lieshout, Esther M M ^b   Roelofs, Hennie M J ^b   Peters, Wilbert H M ^b   Manni, Johannes J ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Dept Otorhinolaryngology Hd/N ^*  (Netherlands)

Author keywords

CYP1A1; Cytochrome P450; Genetic polymorphism; Glutathione S transferase; GSTM1; GSTT1; Head and neck cancer; Tumor marker

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PYRIMIDINE NUCLEOTIDE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP1A1; DISEASE SUSCEPTIBILITY; FEMALE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0009568380     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980301)82:5<936::AID-CNCR20>3.0.CO;2-0     Document Type: Article

References (61)

1. IARC. Cancer incidence in five continents. IARC monographs on the evaluation of carcinogenesis risks of chemicals to humans. Lyon, France: IARC, 1987:88.
2. Tomatis L. Cancer, causes, occurrence and control. Lyon, France: IARC, 1990:100.
3. Merletti F, Boffetta P, Ciccone G, Mashber A, Terracini B. Role of tobacco and alcohol beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Res 1989;49:4919-24.
4. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
5. Chow CH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 1993;55:538-40.
6. Pelkonen O, Nebert DW. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 1982;34:189-222.
7. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 1991;51:5023-44.
8. Sryfter K, Hemminki D, Sryfter W, Szmeja Z, Banaszewski J, Yang K. Aromatic DNA adducts in larynx biopsies and leucocytes. Carcinogenesis 1994;15:2195-9.
9. Degawa M, Stern SJ, Martin MV, Guengerich FP, Fu PP, Ilett KF, et al. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 1994;54:4915-9.
10. Mannervik B, Danielsen UH. Glutathione transferases: structure and catalytical activity. CRC Crit Rev Biochem 1988; 23:283-337.
11. Board P, Coggan M, Johnson P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990;48: 357-69.
12. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993;30:281-380.
13. Hayes JD, Pulford DJ. The glutathione S-transferases supergene family: regulation of GST and contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 1995;31:445-600.
14. Lin HJ, Han C-Y, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994;15: 1077-81.
15. Board PG. Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 1981;33:36-43.
16. Board PG. Gene deletion and partial deficiency of the glutathione S-transferase (ligandin) system in man. FEBS Lett 1981;135:12-4.
17. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active of trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 1988;85:7293-7.
18. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vianio H. The GST M1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14: 1479-81.
19. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferases (class Mu) as a marker for susceptibility to lung cancer: a follow up study. Carcinogenesis 1990;11:33-6.
20. Kihara M, Kihara M, Noda K, Okamoto N. Increased risk of lung cancer in Japanese smokers with class Mu glutathione S-transferase gene deficiency. Cancer Lett 1993;71:151-5.
21. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53:2313-8.
22. Lafuente A, Pujol F, Carretero P, Villa J, Cuchia A. Human glutathione S-transferase mu deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993;68:49-54.
23. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996;17:1855-9.
24. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996;56:3915-25.
25. Seidegard J, Pero RW, Miller DG, Beatty EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986;7:751-3.
26. Shanley SM, Chevenix-Trench G, Palmer J, Hayward N. Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. Carcinogenesis 1995;16:2003-4.
27. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and controls. Cancer Res 1993;53:1004-11.
28. Lin HJ, Probst NM, Ingles SA, Han C-Y, Lin BK, Lee DB, et al. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 1995; 55:1224-6.
29. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cytochrome P450IA1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer. Cancer Res 1995;55:3483-5.
30. Rebbeck T, Rosvold EA, Duggan DJ, Zhang J, Buetow KH. Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol Biomarkers Prev 1994;3:511-4.
31. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995;16:2331-6.
32. Heagerty A, Smith A, English J, Lear J, Perkins W, Bower B, et al. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotype, skin type and male gender. Br J Cancer 1996;73:44-8.
33. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
34. Abdelrahman SZ, Elzein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996;107: 229-33.
35. Kerb R, Brockmöller J, Cascorbi I, Roots I. Glutathione S-transferase of class Mu and Theta as modulators of lung cancer susceptibility. ISSX Proc 1995;7:76.
36. Heidelberger C. Chemical carcinogenesis. Annu Rev Biochem 1975;44:79-121.
37. Guengerich FP. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988;48:2946-54.
38. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 1982;42:4875-917.
39. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988;40:243-88.
40. Cuzick J, Routledge MN, Jenkins D, Garner RC. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer 1990;45:673-8.
41. Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolite activation of chemical carcinogens and toxins. Drug Metab Rev 1994;26:165-83.
42. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tuckey RH. Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res 1990;50:3367-76.
43. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Tonioli P, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994;15:2961-3.
44. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem 1991;110:407-11.
45. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associate with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993;53:2994-8.
46. Kawajiri K, Nakachi K, Imai K, Yoshi A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P450IA1 gene. FEBS Lett 1990;263:131-3.
47. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51: 5177-80.
48. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 1993;53: 3486-92.
49. Sugimuru H, Suzuki I, Hamada GS, Iwase T, Takahashi T, Nagura K, et al. Cytochrome P-4501A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol Biomarkers Prev 1994;3:145-8.
50. Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, et al. Human CYP1A1 (cytochrome P450) gene: lack of association between the Msp1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1991;1:20-5.
51. Hirvonen A, Husgafvel-Pursiainen K, Karjarlainen A, Anttila S, Vainio H. Pointmutational Msp1 gene and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish population. Cancer Epidemiol Biomarkers Prev 1992;1:485-9.
52. Drakoulis N, Cascorbi I, Brockmöller J, Gross CR, Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: a exon-7 mutation (4889 A to G), and a T to C mutation in the 3′ flanking region. Clin Invest 1994;72:240-8.
53. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1) cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
54. Chevenix-Trench E, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995; 16:1655-7.
55. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H. Glutathione S-transferase genotypes as risk factor for head and neck cancer. Am J Surg 1995;170:499-501.
56. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin C, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric, and colorectal cancers. Carcinogenesis 1996;17:881-4.
57. Jahnke V, Strange R, Matthias C, Fryer AA. Erste Ergebnisse über Glutathion S-Transferase GSTM1 und GSTT1 Genotypen und die genetische Prädisposition beim Larynxkarzinom. Laryngol Rhinol Otol 1995;74:691-4.
58. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996;56:1974-7.
59. Goto I, Yoneda S, Yamamoto M, Kawajiri K. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res 1996;56:3725-30.
60. Yu M-W, Gladek-Yarborough A, Chiamprasert S, Sanbella RM, Liaw Y-F, Chen C-J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995;109:1266-73.
61. Alexandrie A-K, Sundberg MI, Seidegard J, Tornling G, Rannung A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age of onset, gender and histological cancer types. Carcinogenesis 1994;15:1785-90.